PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 175 filers reported holding PRECIGEN INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,628 | -91.0% | 3,259 | -92.7% | 0.00% | – |
| Q2 2023 | $51,254 | +40.5% | 44,569 | +29.5% | 0.00% | – |
| Q1 2023 | $36,481 | -43.9% | 34,416 | -19.6% | 0.00% | – |
| Q4 2022 | $65,039 | -41.4% | 42,789 | -18.5% | 0.00% | – |
| Q3 2022 | $111,000 | +33.7% | 52,527 | -14.7% | 0.00% | – |
| Q2 2022 | $83,000 | -59.9% | 61,586 | -37.0% | 0.00% | – |
| Q1 2022 | $207,000 | -88.6% | 97,769 | -80.0% | 0.00% | -100.0% |
| Q4 2021 | $1,813,000 | +47.9% | 488,778 | +98.9% | 0.00% | 0.0% |
| Q3 2021 | $1,226,000 | -61.7% | 245,721 | -50.0% | 0.00% | -50.0% |
| Q2 2021 | $3,205,000 | -6.4% | 491,567 | -1.1% | 0.00% | 0.0% |
| Q1 2021 | $3,424,000 | +467.8% | 496,961 | +739.4% | 0.00% | – |
| Q4 2020 | $603,000 | +394.3% | 59,202 | +70.4% | 0.00% | – |
| Q3 2020 | $122,000 | -65.2% | 34,747 | -50.7% | 0.00% | – |
| Q2 2020 | $351,000 | -48.5% | 70,476 | -64.9% | 0.00% | -100.0% |
| Q1 2020 | $681,000 | – | 200,503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |